Masimo Wins FDA Nod for Opioid-Induced Respiratory Depression Detection

Masimo, a Danaher company, has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for an opioid-induced respiratory depression (OIRD) detection capability in its Radius VSM wearable continuous patient monitor.

The new feature is enabled by the company’s next-gen smartSET pulse oximetry sensor platform. It uses advanced pattern recognition to analyze continuous physiologic data so clinicians can identify early signs of respiratory comprise in hospital patients receiving opioid therapy.

This clearance is the first implementation of Masimo’s OIRD detection capability in a hospital monitoring device. It combines SET’s signal quality with AI enabled analysis to expand pulse oximetry’s role from monitoring patient status to surfacing actionable insights. The company is developing additional pattern-recognition algorithms for the smartSET platform.

smartSET was developed to provide continuous parameter insights by analyzing complex physiological patterns and relationships instead of relying on individual parameters alone. Its design also allows for future integration into additional hospital monitoring solutions.

The OIRD feature includes visual alarms that alert clinicians to changes in a patient’s condition and escalate as OIRD risk grows. The alarms are shown on the device’s display and can be relayed to remote and centralized monitoring stations.

“Opioid-Induced Respiratory Depression remains a critical patient-safety concern,” said Dr. Basil Matta, chief medical officer at Masimo. “With OIRD detection, Masimo is bringing advanced pattern recognition to continuous, wearable monitoring to help clinicians identify earlier changes in a patient’s respiratory status that may not be apparent through traditional approaches. This capability reflects our ongoing focus on working closely with clinicians to address complex patient-safety challenges with meaningful innovation. OIRD detection on Radius VSM will help expand continuous monitoring from simple measurement to meaningful insight, supporting safer care throughout the hospital.”